Pesquisar
3D Systems Corp
DDDAdicionar à lista de desejos
3.020USD
-0.265-8.08%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
443.78MValor de mercado
6.30P/L TTM
Mais detalhes de 3D Systems Corp Empresa
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
Informações de 3D Systems Corp
Código da empresaDDD
Nome da Empresa3D Systems Corp
Data de listagemMar 26, 2011
CEOGraves (Jeffrey A)
Número de funcionários1833
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 26
Endereço333 Three D Systems Cir
CidadeROCK HILL
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal29730
Telefone18033263900
Sitehttps://www.3dsystems.com/
Código da empresaDDD
Data de listagemMar 26, 2011
CEOGraves (Jeffrey A)
Executivos da empresa 3D Systems Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
915.82K
-0.94%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
--
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
269.35K
-10.91%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
--
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
--
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Mr. Thomas W. Erickson
Mr. Thomas W. Erickson
Independent Director
Independent Director
--
--
Mr. Charles G. (Chip) Mcclure, Jr.
Mr. Charles G. (Chip) Mcclure, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Malissia R. Clinton
Ms. Malissia R. Clinton
Independent Director
Independent Director
--
--
Dr. Jeffrey A. (Jeff) Graves, Ph.D.
Dr. Jeffrey A. (Jeff) Graves, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
915.82K
-0.94%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
--
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
269.35K
-10.91%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
--
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
--
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Products
223.41M
57.74%
Services
163.50M
42.26%
Por RegiãoUSD
Nome
Receita
Proporção
USA
221.04M
57.13%
EMEA
135.82M
35.11%
Asia/Pacific
26.63M
6.88%
Americas Excluding USA
3.41M
0.88%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Products
223.41M
57.74%
Services
163.50M
42.26%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
State Street Investment Management (US)
7.73%
BlackRock Institutional Trust Company, N.A.
6.04%
Bank of Nova Scotia
5.16%
Vanguard Capital Management, LLC
3.96%
Capital Research Global Investors
3.54%
Outro
73.58%
Investidores
Investidores
Proporção
State Street Investment Management (US)
7.73%
BlackRock Institutional Trust Company, N.A.
6.04%
Bank of Nova Scotia
5.16%
Vanguard Capital Management, LLC
3.96%
Capital Research Global Investors
3.54%
Outro
73.58%
Tipos de investidores
Investidores
Proporção
Investment Advisor
28.45%
Investment Advisor/Hedge Fund
17.67%
Hedge Fund
9.73%
Bank and Trust
5.33%
Research Firm
3.48%
Individual Investor
3.11%
Family Office
0.97%
Venture Capital
0.22%
Pension Fund
0.07%
Outro
30.97%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
519
94.39M
64.62%
-18.65M
2025Q4
525
86.77M
65.34%
-385.78K
2025Q3
554
87.16M
66.88%
+21.71M
2025Q2
554
65.46M
65.17%
-1.74M
2025Q1
566
67.79M
64.38%
-19.36M
2024Q4
570
74.57M
59.91%
+2.30M
2024Q3
566
72.36M
70.47%
-13.78M
2024Q2
562
86.29M
71.34%
-546.64K
2024Q1
569
86.87M
74.59%
-12.80M
2023Q4
580
87.85M
72.95%
+717.28K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
State Street Investment Management (US)
11.36M
7.78%
+1.56M
+15.88%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
8.87M
6.07%
-101.84K
-1.14%
Dec 31, 2025
Bank of Nova Scotia
7.58M
5.19%
-603.50K
-7.38%
Dec 31, 2025
Capital World Investors
5.21M
3.57%
--
--
Dec 31, 2025
Two Sigma Investments, LP
4.89M
3.35%
+648.78K
+15.31%
Dec 31, 2025
D. E. Shaw & Co., L.P.
3.32M
2.27%
+131.44K
+4.12%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.04M
2.08%
-116.51K
-3.69%
Dec 31, 2025
Silverberg Bernstein Capital Management, LLC
2.57M
1.76%
+233.66K
+9.99%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Pacer BlueStar Engineering the Future ETF
9.74%
ProShares S&P Kensho Smart Factories ETF
6.3%
3D Printing ETF
3.91%
State Street SPDR S&P Kensho New Econ Comp ETF
0.76%
Gabelli Automation ETF
0.63%
iShares Micro-Cap ETF
0.07%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver Mais
Pacer BlueStar Engineering the Future ETF
Proporção9.74%
ProShares S&P Kensho Smart Factories ETF
Proporção6.3%
3D Printing ETF
Proporção3.91%
State Street SPDR S&P Kensho New Econ Comp ETF
Proporção0.76%
Gabelli Automation ETF
Proporção0.63%
iShares Micro-Cap ETF
Proporção0.07%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.03%
iShares Russell 2000 Value ETF
Proporção0.02%
Global X Russell 2000 ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
